Researchers recently presented a new method that considers how already existing lesions grow over time as an indicator of disease progression.

Vessel wall imaging—an MRI technique that offers high resolution images of the vessel wall—may hold clues as to the mechanisms by which COVID infections continue to cause neurologic symptoms after initial recovery in some patients.  

Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.

In the case of a convicted murderer, a New York neuro specialist cited a slew of neuroimaging findings that indicate “severe dysfunction” that could have numbed the defendant’s “brakes of inhibition.” 

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.

Bhvita Jani, research manager, Signify Research, explains some key trends and technology advances in the magnetic resonance imaging (MRI) market leading into the Radiological Society of North America (RSNA) 2022 meeting. 

Signify Research outlines several key technologies and trends in MRI to look for at the Radiological Society of North America 2022 meeting.

In a letter to providers, the agency recommends Philips clients in the affected product category consider any of three steps to cope with the interruption.